Imitrex "Authorized" Generic Launch Planned In Q4 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline and Dr. Reddy's reach settlement agreement on the migraine tablets allowing a generic launch several months prior to patent expiration.